Bristol-Myers Squibb (BMY)
$47.56
0.23 (0.49%)
BMY Stock Quote Delayed 15 Minutes
Previous Close
$47.56
Market Cap
77.74B
PE Ratio
83.44
EPS
0.57
Volume (Avg. Vol.)
10.19M
Day's Range
47.20 - 48.03
52-Week Range
44.30 - 63.69
Dividend & Yield
1.60 (3.36%)
BMY Stock Predictions, Articles, and Bristol-Myers Squibb News
2 Dividend Stocks to Buy That Are Better Than 3M Stock
MMM stock has fallen 25% in the past six weeks since announcing weaker-than-expected Q1 earnings. 3M stock has been weak since then.
Credit Suisse Absolutely Is Right to Double Down on Pfizer Stock
Buy Pfizer stock on this current round of weakness. The underpinnings are bullish for 2020 and beyond.
Bristol-Myers Squibb Earnings: BMY Stock Pops on Q1 Beat
Bristol-Myers Squibb earnings for the first quarter of 2019 have BMY stock up Thursday on an earnings per share and revenue beat.
3 Big Stock Charts for Thursday: Discovery, Norfolk Southern and Bristol-Myers Squibb
The stock charts of BMY, DISCA and NSC stock merit the closest looks headed into the latter part of the week.
Why Is Bristol-Myers Near 52-Week Lows?
Investors are punishing Bristol-Myers on the markets more than they should. BMY stock's acquisition of Celgene isn't the only reason.
BMY Stock Looks Really Appetizing as the Celgene Merger Approaches
Is Bristol-Myers Squibb stock a buy now? If you're patient enough to wait out the merger jitters, there's a lot to like.
Is AstraZeneca Stock Worth Buying Before Earnings?
AZN stock is great to own, but you should choose your entry points carefully, as AstraZeneca has some short-term risks ahead.
3 Big Stock Charts for Monday: Bristol-Myers Squibb, Centurylink and Campbell Soup Company
The stock charts of CTL, CPB and BMY look ready to start the new trading week on the verge of tradeworthy moves. Here are levels to watch.
Is Celgene Stock Still Worth Holding Onto in the Long Run?
Celgene and Bristol-Myers got the green light from shareholders to move forward on the deal. More upside awaits for CELG stock.
5 Top Stock Trades for Monday: Lyft, RH, Celgene, Wells Fargo
Restoration Hardware, Bristol-Myers, Celgene, Lyft's IPO and Wells Fargo are our top stock trades to watch for Monday.
Friday’s Vital Data: Square, Southwest Airlines and Celgene
Options trading was buzzing in Southwest Airlines, Celgene, and Square on Thursday. Here are the metrics that matter moving forward.
5 Top Stock Trades for Friday: CELG, SQ, FIT, BOX
Bristol-Myers deal for Celgene is in doubt, while Box, Square, JD.com and Fitbit are moving on earnings. Here's are top stock trades for Friday.
Celgene Stock (CELG) Slides Lower on Opposition to Bristol-Meyers Deal
Celgene stock was on its way down Thursday following news that major investors are against a deal with Bristol-Meyers (BMY).
Friday’s Vital Data: Bristol-Myers Squibb, Intel and Activision Blizzard
Options trading was buzzing in Bristol-Myers, Activision Blizzard and Intel hursday. Here are the metrics that matter moving forward.
Celgene vs. Gilead Stock: What’s the Better Biotech Buy?
Gilead stock has been stagnating, but there are other choices for investors. How about considering Celgene over GILD stock?
5 Top Stock Trades for Friday: Freeport, Xilinx, Lam Research
Earnings are the big story Friday, so it make sense our top stock trades include Ford, Xilinx, Freeport-McMoran, Bristrol-Myers and more.
All Signals Are Positive for Buying Abbott Laboratories
Abbott is about to report another quarter to cap 2018's strong annual performance. ABT stock also offers a dividend for income investors.
Is It Time to Sell Celgene Stock After the Bristol-Myers Squibb Offer?
Celgene shareholders who bought CELG stock at lows last year started 2019 on a bright note; Bristol-Myers is buying it for $74 billion.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
C
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!
